Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
ICI India: Accruing benefits - Views on News from Equitymaster
  • E-MAIL
  • A  A  A
  • Aug 29, 2002

    ICI India: Accruing benefits

    This is one of the never ending restructuring story that the stock markets have been hearing for more than five years. But after languishing for a significant amount of time, ICI India finally stepped on the restructuring pedal in FY02. Starting 1QFY03, it has started to reap the benefits of the same.

    (Rs m) 1QFY02 1QFY03 Change
    Net sales 1,779 1,782 0.2%
    Other Income 20 1 -95.5%
    Expenditure 1,677 1,575 -6.1%
    Operating Profit (EBDIT) 102 208 103.8%
    Operating Profit Margin (%) 5.7% 11.7%  
    Interest (12) 13 -
    Depreciation 56 60 7.9%
    Profit before Tax 78 135 74.1%
    Extraordinary items (12) (8) -
    Tax 19 46 141.1%
    Profit after Tax/(Loss) 47 81 72.6%
    Net profit margin (%) 2.6% 4.6%  
    No. of Shares (m) 40.9 40.9  
    Diluted Earnings per share* 4.6 8.0  
    P/E Ratio (x)   11.3  
    (* annualised)      

    The first quarter performance of the company is a clear vindication of the benefits accruing from the sale of some of its divisions. While revenue growth at 0.2% may not be impressive, it is on account of sale of its pharmaceutical division to Nicholas Piramal last year. This division contributed to 8% of revenues in FY02. On a like-to-like basis, revenues have actually increased by 16% in 1QFY03. ICI's industrial chemical units and paint division were believed to have been the key growth driver in the same period.

    Revenue mix…
    (Rs m) 1QFY03 (% of sales) FY02 (% of sales)
    Segment Revenue       .
    Paints 8,840 49.6% 32,491 44.8%
    Industrial Specialities 3,484 19.5% 13,158 18.1%
    Industrial Chemicals 5,616 31.5% 21,950 30.3%
    Pharmaceuticals - - 5,464 7.5%
    Total of the above 17,940 100.7% 73,063 100.7%
    Less: Inter-segment revenue 117 0.7% 527 0.7%
    Net Sales 17,823 100.0% 72,536 100.0%

    On the paint division front, the company has a strong presence in the Eastern region where Berger is the other large player. As far as the distribution network is concerned, it is the second largest in the sector. ICI has been increasing the number of dealer tinting machines over the last two years. Robustness in housing demand and a strong reach would continue to drive paint volumes in the coming quarters.

    Operating margins have almost doubled during the quarter as the paint division has turned profitable in 1QFY03. At the PBIT level, ICI's paint division reported a net loss of Rs 94 m in FY02. But in 1QFY03, the division posted a PBIT of Rs 12 m. This combined with increased capacity utilisation has enabled the company to double its operating profits on a like-to-like basis in 1QFY03.

    The stock currently trades at Rs 90 implying a P/E multiple of 11.5x 1QFY03 annualised earnings. The stock has risen more than 100% in the last one year. Though valuations are on the lower side on a peer valuation basis (Asian Paints trades at a P/E multiple of 16x), the diversified business nature will continue to weigh on profits. It had ventured into starch and fragrance manufacturing last year, in line with its parent company, ICI Plc. It acquired a majority stake in Quest international India, a joint venture between Quest International BV and Hindustan Lever, for a consideration of Rs 1,520 m. It remains to be seen how the new divisions perform in the coming years. Also, with crude prices already touching US$ 30 per barrel (key raw material for paint division), margin growth might be limited.



    Equitymaster requests your view! Post a comment on "ICI India: Accruing benefits". Click here!


    More Views on News

    Asian Paints: Destocking Ahead of GST Impair Sales Volumes (Quarterly Results Update - Detailed)

    Aug 17, 2017

    Asian Paints registers 20.1% YoY decline in profits during 1QFY18 with low single-digit volume growth in the decorative paints segment.

    Asian Paints: Good Performance Across Segments (Quarterly Results Update - Detailed)

    May 18, 2017

    Asian Paints registers 10.4% YoY growth in profits during 4QFY17 with double-digit volume growth in the decorative segment.

    More Views on News

    Most Popular

    A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

    Aug 10, 2017

    Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

    The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

    Aug 8, 2017

    'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    Bitcoin Continues Stellar Rise(Chart Of The Day)

    Aug 10, 2017

    Bitcoin hits an all-time high, is there more upside left?

    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms


    Aug 21, 2017 11:15 AM


    • Track your investment in AKZO NOBEL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
    • Add To MyStocks


    Detailed Financial Information With Charts